Home / Evidence, Value & Access / US Managed Markets

US Managed Markets Services

Scientific value story development and payer engagement

Evidence-driven strategies for US managed markets

Navigating US managed markets requires a meticulous understanding of market dynamics, pricing strategies, and payer expectations. Certara’s expertise lies in crafting data-backed value propositions that resonate with key stakeholders. From early value assessments to ICER response frameworks, our comprehensive services are designed to provide a competitive edge.

Translate impactful science to commercial success

With a 20+ year track record in US market access, Certara delivers strategies that spur success.

Optimize launch price and coverage

Research-based evaluation of key value drivers in early phases of development.

Substantiate innovative product value

Strategic, impartial and dependable assessments of asset value.

Capitalize on increasing reliance on real-world data

Structured value frameworks to support a comprehensive response.

US managed markets services grounded in timely and insightful evidence

Market landscape assessments

Certara helps you construct a detailed view of the current and future reimbursement landscape as well as the needs and objectives of decision makers in each market. As part of Certara’s early value strategy offering, a market landscape assessment sets the foundation for pricing and access strategies tailored to US managed markets.

Target Product Profile (TPP) evaluation

Is your target product profile (TPP) complete and does it address the key value drivers when compared to leading current comparators and future competition? Certara experts can help you establish key attributes to evaluate, provide a gap analysis and product value proposition.

Investor due diligence

Certara provides strategic, impartial assessments validated by scientific and commercial expertise to guide innovators as they explore financing, partnership and acquisition deals.

Value frameworks and ICER assessments

Ensure readiness for ICER reviews with structured response playbooks, competitive pricing scenario planning, and established value frameworks such as NCCN, ASCO and ICER.

Proven value and access strategies throughout drug development

Target patient population (TPP) support

Landscape analyses, testing and competitive scenario simulations.

Gross-to-net (GTN) modeling

Leverage qualitative and quantitative pricing studies.

Strategic clinical development review

Assistance in clinical strategy development to maximize product value.

Preparation for investor and partner meetings

Guidance for innovators in substantiating market value.

U.S. Access leadership

1 / 1

Experts

Maximilian Vargas, PhD, MBA

Vice President, US Access Strategy

Maximilian has over a decade of experience in evidence-based value and access strategies, helping clients succeed in the US market.

Connect

Why choose Certara

Certara offers unparalleled expertise in US managed markets, combining scientific precision and commercial acumen. Our evidence-driven approach ensures that your product achieves payer acceptance, healthcare provider preference, and patient access. Trust in our proven methodologies and innovative tools to navigate the complexities of the US market.

Contact our team

Investor value created for Certara's biotech clients since 2018.

Years of experience optimizing U.S. Value and Access strategies.

Commercial opportunities assessed annually.

Additional US managed markets resources

View all

1 / 3

Brochure

Evidence and Access Overview

Discover Certara’s holistic approach to market access.

2 / 3

Blog

CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of

3 / 3

Case Study

Early Value Assessment in Gene Therapy Clinical Trial Design

Contact us

Certara is your trusted partner for navigating US managed markets. Reach out to our team to discuss how we can support your efforts in optimizing value and access strategies.

Why contact us?

Proven track record in delivering access strategies.

20+ years of expertise and industry trust.

Comprehensive solutions tailored to your needs.

Send an inquiry

Discover related products and services

Discover Certara's comprehensive Real-World Evidence Services. We provide innovative RWE solutions for pharma, empowering regulatory, market access, and clinical strategies.

Certara’s Market Access & Commercial solutions provide strategic insights and tools to optimize pricing, reimbursement, and market entry strategies.

With 25+ years of HEOR consulting expertise, we offer HTA health economic analyses, clinical trial analytics for HTA applications, epidemiology models, and more.